CLINICAL_TRIALS
withdrawal
· 2014-11-19
Clinical Trial Update: Cardioprotective Effects of Increased Endogenous Erythropoietin After Normobaric Oxygen Breathing [NA]
Summary
A clinical trial investigating whether increasing endogenous erythropoietin through normobaric oxygen breathing has cardioprotective effects in healthy voluntee…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Healthy, Coronary Artery Bypass Graft | NA | Status: WITHDRAWN